Trademark: 79249068
Word
SANOFI GENZYME
Status
Registered
Status Code
700
Status Date
Tuesday, February 18, 2020
Serial Number
79249068
Registration Number
5986713
Registration Date
Tuesday, February 18, 2020
Mark Type
4000
Filing Date
Monday, May 28, 2018
Published for Opposition
Tuesday, December 3, 2019

Trademark Owner History
SANOFI - Original Registrant

Classifications
41 Education and training relating to health, namely, arranging seminars, conferences and congresses in the field of health care; publication of magazines, books and guides; training relating to health using electronic and digital tools, namely, providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of health care
40 Custom manufacture of products relating to health, namely, pharmaceuticals and medicines by pharmaceutical compounders
9 Software relating to health, namely, downloadable computer software for database management in the field of pharmaceutical and medical developments, downloadable software accessible via the internet or mobile phone applications for monitoring and tracking blood glucose levels, downloadable mobile software in the nature of interactive games in the field of healthcare; CD-ROMs featuring information about health; medical imaging software
5 Pharmaceutical and medicinal preparations for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; sanitary preparations for medical purposes; dietetic food and beverage substances adapted for medical use; pharmaceutical preparation for use as replacement enzyme and for the prevention of adhesion during medical surgeries; reagents for medical diagnosis; chemical preparations for medical and pharmaceutical use, namely, for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, rare blood disorders, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; vaccines; nutritional supplements; plant extracts for pharmaceutical purposes; pharmacological preparations for skin care
16 Printed matter, namely, bulletins, magazines, periodicals, books, journals, and posters, all in the field of health
38 Telecommunication services, namely, transmission of information by telephone, television, and by computer terminals via Internet sites in the field of health; transmission of information for others relating to health, communication of information for patients or health professionals via computers, via the Internet, television and radio; provision of online chat rooms and online forums for transmission of messages among Internet users concerning health care, medicines and pharmaceutical and medical developments
3 Non-medicinal cosmetic preparations for hygiene, skin care and care; cosmetic preparations
35 Advice in business, namely, business management advice; advice services, namely, provision of commercial information to the consumer regarding products; advertising and marketing services; distribution services, namely, distribution of products and information on pharmaceutical products for advertising purposes; business administration and management of business affairs in the field of health; promoting public awareness regarding healthcare via printed material
1 Chemicals for use in the manufacture of pharmaceutical and cosmetic substances and preparations; full line of enzymes for laboratory diagnosis and enzymes for industrial use, not for medical purposes
44 Consultancy in the field of pharmaceuticals and healthcare; provision of medical information and information relating to health via awareness campaigns
10 Medical apparatus and instruments, namely, blood glucose monitors, blood glucose monitor kits comprising blood glucose monitors, lancets and control solutions, insulin injectors sold empty, asthma inhalers for medical and therapeutic use sold empty; surgical apparatus and instruments; apparatus for imaging and X-Ray apparatus for medical use; inhalers for therapeutic use sold empty and parts and fittings therefor; devices for the injection of medicines, namely, pens for injection
42 Scientific and technological services, namely, research in the fields of chemistry, biology and pharmacy, creation and development of software and databases, clinical studies in the nature of chemistry, biology and pharmacy laboratory research in the field of health, engineering services relating to research and development of enzymes and genetics

Trademark Events
Mar 17, 2023
Change Of Name/Address Rec'd From Ib
Jun 26, 2020
Final Decision Transaction Processed By Ib
Jun 6, 2020
Final Disposition Notice Sent To Ib
Jun 6, 2020
Final Disposition Processed
May 18, 2020
Final Disposition Notice Created, To Be Sent To Ib
Feb 18, 2020
Registered-Principal Register
Jan 8, 2020
Review Of Correspondence Complete - Address Updated
Dec 10, 2019
Correspondence Received In Law Office
Dec 27, 2019
New Representative At Ib Received
Dec 3, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 3, 2019
Published For Opposition
Nov 13, 2019
Notification Of Notice Of Publication E-Mailed
Nov 11, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 11, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 30, 2019
Assigned To Lie
Oct 23, 2019
Examiners Amendment Mailed
Oct 22, 2019
Approved For Pub - Principal Register
Oct 22, 2019
Examiner's Amendment Entered
Oct 22, 2019
Examiners Amendment -Written
Oct 1, 2019
Assigned To Examiner
Jul 25, 2019
Teas/Email Correspondence Entered
Jul 24, 2019
Correspondence Received In Law Office
Jul 24, 2019
Teas Response To Office Action Received
Feb 22, 2019
Refusal Processed By Ib
Feb 1, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Feb 1, 2019
Refusal Processed By Mpu
Jan 19, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jan 18, 2019
Non-Final Action Written
Jan 18, 2019
Application Filing Receipt Mailed
Jan 14, 2019
Assigned To Examiner
Jan 14, 2019
New Application Office Supplied Data Entered
Jan 3, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24